Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / REVO Oncology Diagnostics Inc.

REVO Oncology Diagnostics Inc.

Stage unknownFrisco, TXOther Health Care
Facts
Year of incorporation
2025sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
1 rounds
  1. Sep 17, 2025
    Form D equity offering · $270,000 (form d sold) · 7 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “REVO Oncology Diagnostics Inc. filed Form D: $270,000 sold of $1,200,000, Other Health Care”
Investors on record
0 edges
No named investor yet.
People
1 officers, 0 directors
Timeline
1
  1. Apr 13, 2026
    REVO Oncology Diagnostics Inc. filed Form D: $270,000 sold of $1,200,000, Other Health Care
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
15 observations
Every observation on this company